It has been observed in bladder cancer that ECRG4 promotes OGN expression by upregulating NFIC, preventing the activation of NF-KB downstream pathways, thus inhibiting cell proliferation and migration81. This evidence concerns the gene NFIC and urinary bladder cancer.